Impact of Cipepofol versus Propofol on Long-Term Cardiovascular Outcomes After TAVR: An Extended Follow-Up of a Randomized Trial

Tingting Ni, Yantian Lv, Laiying Zhou, Jing Yu, Xincheng Tao, Han Cao, Yuanyuan Yao, Min Yan

Open source

DOI: 10.2147/dddt.s621481
Published: 2026-09
Container: Drug Design, Development and Therapy
Publisher: Informa UK Limited
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.2147/dddt.s621481,
  title = {Impact of Cipepofol versus Propofol on Long-Term Cardiovascular Outcomes After TAVR: An Extended Follow-Up of a Randomized Trial},
  author = {Tingting Ni and Yantian Lv and Laiying Zhou and Jing Yu and Xincheng Tao and Han Cao and Yuanyuan Yao and Min Yan},
  year = {2026},
  journal = {Drug Design, Development and Therapy},
  doi = {10.2147/dddt.s621481},
  url = {https://doi.org/10.2147/dddt.s621481}
}

RIS

TY  - JOUR
TI  - Impact of Cipepofol versus Propofol on Long-Term Cardiovascular Outcomes After TAVR: An Extended Follow-Up of a Randomized Trial
AU  - Tingting Ni
AU  - Yantian Lv
AU  - Laiying Zhou
AU  - Jing Yu
AU  - Xincheng Tao
AU  - Han Cao
AU  - Yuanyuan Yao
AU  - Min Yan
PY  - 2026
JO  - Drug Design, Development and Therapy
DO  - 10.2147/dddt.s621481
UR  - https://doi.org/10.2147/dddt.s621481
ER  -

APA

Ni, T., Lv, Y., Zhou, L., Yu, J., Tao, X., Cao, H., Yao, Y., & Yan, M. (2026). Impact of Cipepofol versus Propofol on Long-Term Cardiovascular Outcomes After TAVR: An Extended Follow-Up of a Randomized Trial. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s621481

Source records

crossref · retrieved 2026-09-25T23:00:06.780Z